DermBiont
Latest round
- Series B
Last raised
- Oct 2023
Total raised
- $56M
Investors
- 9
About DermBiont
DermBiont, Inc.Founded in 2017 and headquartered in Boston, US, DermBiont, Inc. specializes in advancing topical therapeutics.DermBiont, Inc. specializes in advancing topical therapeutics primarily aimed at addressing unmet needs in rare disease oncology and aesthetic dermatology. The company’s core product offerings revolve around innovative small molecules that target specific dermatological conditions, enhancing treatment efficacy through localized delivery mechanisms. These therapeutics are designed to improve patient outcomes by directly addressing the pathophysiology of skin-related issues, thereby catering to a diverse client base that includes healthcare providers, dermatologists, and patients seeking effective treatment options.DermBiont, Inc. operates on a revenue model that emphasizes direct-to-consumer sales, partnerships with healthcare providers, and potential collaborations with research institutions. Revenue is generated through the sale of proprietary therapeutics, which are often offered as part of specialized treatment regimens tailored to individual patient needs. The company establishes pricing structures based on the therapeutic value of its products, which may involve one-time purchases or subscription plans for ongoing treatment protocols. Specific flagship offerings—central to its revenue stream—are designed to cater to both the rare disease and aesthetic markets, thereby solidifying DermBiont’s position within the competitive landscape of dermatological therapeutics.In October 2023, DermBiont, Inc.76 mn. Additionally, DermBiont aims to expand its market reach into new geographical regions, enhancing accessibility to its innovative treatments while capitalizing on its existing market presence.
Who invested in DermBiont
9 investors across 5 rounds
See all investors in DermBiont
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DermBiont
Who invested in DermBiont?
DermBiont has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DermBiont raised?
DermBiont has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did DermBiont last raise money?
DermBiont's most recent round on record is a Series B, in Oct 2023.
What does DermBiont do?
DermBiont is a healthcare specialists company.
Where is DermBiont headquartered?
DermBiont is headquartered in Boston, US.
Which VCs invest in companies like DermBiont?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at DermBiont's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like DermBiont? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.